RecruitingNCT06096688
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Studying Genetic intestinal disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Weill Medical College of Cornell University
- Principal Investigator
- Steven M Lipkin, MDWeill Medical College of Cornell University
- Enrollment
- 1120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2026
Study locations (1)
- NYP/Weill Cornell Medicine, New York, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06096688 on ClinicalTrials.govOther trials for Genetic intestinal disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06177938Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath MarkersETH Zurich
- RECRUITINGNANCT05398380Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational ResearchHospital Vall d'Hebron
- ACTIVE NOT RECRUITINGNANCT07555639An Integrated Genomic Approach to Assess Genetic Risk and Drug SensitivityFondazione Policlinico Universitario Agostino Gemelli IRCCS
- ACTIVE NOT RECRUITINGNCT04157322Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal MetastasisUniversity of Chicago
- ACTIVE NOT RECRUITINGNCT04087239The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT StudyUniversity of Zimbabwe